Join the club for FREE to access the whole archive and other member benefits.

Rob Konrad Maciejewski

CEO and Co-Founder at Biolytica

Since starting his own company at the age of 15, Rob has accumulated over 20 years’ worth of experience in the fields of entrepreneurship, strategic consulting, and international management. After consulting for some of the leading health and pharmaceutical companies during his time with one of the BIG4 professional services firms, Rob went on to serve as the Head of International Marketing for a leading Swiss retail group (encompassing over 25 individual companies). In addition, he co-founded a software development company and was the CEO of two renowned enterprises in the International Health Insurance and Health Management fields. Rob also holds a doctorate in Public Healthcare Management.

As a longevity enthusiast and lifelong tech geek, Rob believes that the more you know about your body, the more you can improve your health and wellbeing. He is currently developing solutions and programs to help others do exactly that.

Visit website: https://www.robkonrad.com/

 robkonradcom

 rmaciejewski

 RobKonradcom

See also: Company Biolytica - Increasing human healthspan and performance through state-of-the-art health data analytics

Details last updated 21-Oct-2022

Rob Konrad Maciejewski is also referenced in the following:

ARDD 2023 - 10th Aging Research & Drug Discovery Meeting

28-Aug-2023 to 01-Sep-2023

Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen

Global Longevity Federation (GLF 2023)

15-May-2023 to 16-May-2023

The conference by Sciinov Group tries to put together an exciting scientific programme focused on longevity

Smart Ageing Summit

08-Jul-2023

Enhance your health span and longevity with these expert talks organized by Oxford Longevity Project

Rob Konrad Maciejewski News

Reason reports back from October's Rejuvenation Startup Summit

Fight Aging! - 19-Oct-2022

Some really exciting developments with quite a few in clinical trials

Read more...